ALS Clinical Trials in Los Angeles

Showing 21-35 of 35 trials

Mexiletine for the Treatment of Muscle Cramps in ALS

NCT01811355

The purpose of this study is to determine if mexiletine is effective for the treatment of muscle cramps in Amyotrophic Lateral Sclerosis (ALS).

Muscle Cramps in Amyotrophic Lateral Sclerosis

Bjorn Oskarsson, MD23 participantsStarted May 2013

Chester, California, United States • La Jolla, California, United States • Los Angeles, California, United States +3 more locations

COMPLETEDPHASE3< 1 mile

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

NCT00021697

The purpose of this study is to compare and evaluate the safety of AVP-923 (dextromethorphan/quinidine) for the treatment of emotional lability in ALS patients.

Amyotrophic Lateral Sclerosis

Avanir Pharmaceuticals100 participantsStarted Jan 2001

Loma Linda, California, United States • Los Angeles, California, United States • San Francisco, California, United States +14 more locations

Mexiletine for the Treatment of Muscle Cramps in ALS

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

ALS Trials in Other Cities

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

PRISM Registry: Pseudobulbar Affect Registry Series

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Determining the Safety of L-serine in ALS

Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity

Other Conditions in Los Angeles